The Zhitong Finance App learned that the Hong Kong stock prospectus submitted by Weimai Company (abbreviation: Weimai) on June 27 expired on December 27 and expired on December 27. China Merchants Securities International and Deutsche Bank were its co-sponsors at the time of submission.

According to the previous prospectus, Weimai is the pioneer and leader of artificial intelligence (“AI”) full-course disease management services in China. The company is committed to using AI to empower the medical service industry, link hospitals, doctors and patients, and restructure the hospital's medical service value chain. In terms of revenue in 2024, Weimai is one of the top three full-course management service providers in China, and is the largest patient-oriented AI-enabled full-course management service provider in China. The company's services cover the patient's entire health management process from before to after treatment.